Neuphoria Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period
Neuphoria Therapeutics Inc. (NEUP) reported Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period of 0 shares for the 9-month period ending 2025-03-31, per its 10-Q filed 2025-05-20.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod · last filed 2025-05-20
- Neuphoria Therapeutics Inc. share-based compensation arrangement by share-based payment award, shares issued in period for the quarter ending 2025-03-31 was 0.00 shares.
- Neuphoria Therapeutics Inc. share-based compensation arrangement by share-based payment award, shares issued in period for the quarter ending 2024-12-31 was 0.00 shares.
- Neuphoria Therapeutics Inc. share-based compensation arrangement by share-based payment award, shares issued in period for the quarter ending 2024-09-30 was 0.00 shares.
- Neuphoria Therapeutics Inc. share-based compensation arrangement by share-based payment award, shares issued in period for the quarter ending 2023-09-30 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 9 month |
|---|---|---|---|
| 2025-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-20 | 0.00 shares derived: sum of 2 quarters · filed 2025-05-20 | 0.00 shares 10-Q · filed 2025-05-20 |
| 2024-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-14 | 0.00 shares 10-Q · filed 2025-02-14 | |
| 2024-09-30 | 0.00 shares 10-Q · filed 2024-11-14 | ||
| 2023-09-30 | 0.00 shares 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |